Home › Sakit sa Suso › California
Pag-aaral pangklinika para sa Sakit sa Suso sa California
6 pag-aaral para sa Sakit sa Suso ang naghahanap ng mga kalahok sa mga site sa California.
Mga Lungsod sa California
Opisyal na teksto ng pag-aaral (English)
ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE) - iSono Health
- UC Davis, Sacramento
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 94 · Kababaihan · Na-update Set 17, 2026 · NCT07505797A Study of Breast Cancer Risk Factors and Outcomes of People in Florida
- University of California, Los Angeles (Specimen Analysis only), Los Angeles
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT06780176Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
- Providence Medical Foundation, Fullerton
- California Research Institute, Los Angeles
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT05386108A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
- Research Site, Duarte
- Research Site, Palo Alto
Nagre-recruitPhase 3
Edad 18 hanggang 130 · Lahat ng kasarian · Na-update Set 8, 2026 · NCT07647328First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- Ellison Clinic at Saint John's, Los Angeles
- UCSF Medical Center at Mission Bay, San Francisco
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 7, 2026 · NCT05768139Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
- Hoag Memorial Hospital Presbyterian, Newport Beach
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 23, 2026 · NCT06993844Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.